Advertisement

AUTHOR

Daniel Koller

Dr Daniel Koller is head of BB Biotech at Bellevue Asset Management.

Three biotech stocks on the cutting edge of medicine
Share tips

Three biotech stocks on the cutting edge of medicine

Investors are only now recognising the vast potential of biotech stocks. Here. Professional investor Dr Daniel Koller of BB Biotech AG picks three of …
31 Jul 2019
Three biotech stocks to buy now
Share tips

Three biotech stocks to buy now

Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.
27 Jul 2018
Biotech’s boom continues
Share tips

Biotech’s boom continues

Professional investor Daniel Koller picks six stocks to profit from the continuing biotech boom.
21 Jul 2017
Five top biotech innovators
Share tips

Five top biotech innovators

Professional investor Dr Daniel Koller picks five innovative biotech stocks to buy now.
28 Oct 2016
Advertisement
Four promising biotech stocks to buy now
Share tips

Four promising biotech stocks to buy now

The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.
27 Nov 2015
Three of the best biotech stocks to buy now
Share tips

Three of the best biotech stocks to buy now

Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.
6 Mar 2015
Biotech’s three biggest innovators
Share tips

Biotech’s three biggest innovators

Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.
3 Mar 2014